Zynerba Pharma (ZYNE) – Hot FDA News
-
Zynerba Pharma (ZYNE) Pivotal CONNECT-FX Trial of Zygel in Fragile X Syndrome Did Not Achieve Statistical Significance
-
Zynerba Pharma (ZYNE) Announces Positive Top Line Results from Exploratory Open Label Phase 2 BRIGHT Trial of Zygel in ASD
-
-
-
-
-
-
Back to ZYNE Stock Lookup